Morbidity and mortality of elderly patients following cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Cytoreductive surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is known to improve survival in selected patients with peritoneal metastasis. However, there is limited data supporting the role of CRS and HIPEC in elderly patients (≥65 years old).

[1]  S. Merigliano,et al.  Outcome of pancreaticoduodenectomy in octogenarians: Single institution's experience and review of the literature. , 2015, Journal of visceral surgery.

[2]  A. Königsrainer,et al.  Overall morbidity but not mortality is increased in elderly patients following cytoreductive surgery and HIPEC , 2015, Langenbeck's Archives of Surgery.

[3]  K. Soo,et al.  Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: the experience of a tertiary Asian center. , 2015, Asian journal of surgery.

[4]  H. Nakahara,et al.  Safety of hepatectomy for elderly patients with hepatocellular carcinoma. , 2014, World journal of gastroenterology.

[5]  F. Roviello,et al.  Short-term outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: preliminary analysis of a multicentre study. , 2014, Anticancer research.

[6]  M. Wiezer,et al.  Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer , 2014, Journal of surgical oncology.

[7]  E. Levine,et al.  Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality , 2013, Annals of Surgical Oncology.

[8]  K. Soo,et al.  Surgical Management of Colorectal Peritoneal Metastases: Treatment and Outcomes Compared with Hepatic Metastases , 2013, Journal of Gastrointestinal Cancer.

[9]  S. Nara,et al.  Perioperative and long-term outcomes after pancreaticoduodenectomy in elderly patients 80 years of age and older , 2013, Langenbeck's Archives of Surgery.

[10]  F. Granath,et al.  Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer , 2012, The British journal of surgery.

[11]  M. Deraco,et al.  Multidimensional Analysis of the Learning Curve for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Surface Malignancies , 2012, Annals of surgery.

[12]  T. Chua,et al.  Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis , 2012, Journal of surgical oncology.

[13]  G. Trimarchi,et al.  Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in elderly patients. , 2011, In vivo.

[14]  E. Steyerberg,et al.  Outcome of esophagectomy for cancer in elderly patients. , 2010, The Annals of thoracic surgery.

[15]  R. J. Haas,et al.  Liver resection of colorectal metastases in elderly patients , 2010, The British journal of surgery.

[16]  M. Nijsten,et al.  Extended Esophagectomy in Elderly Patients with Esophageal Cancer: Minor Effect of Age Alone in Determining the Postoperative Course and Survival , 2010, Annals of Surgical Oncology.

[17]  T. Chua,et al.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  T. Chua,et al.  Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results , 2009, Journal of Cancer Research and Clinical Oncology.

[19]  P. Sugarbaker,et al.  Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  D. Morris,et al.  A Systematic Review and Meta-analysis of the Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Gastric Cancer , 2007, Annals of Surgical Oncology.

[21]  K. Geisinger,et al.  Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. , 2007, Journal of the American College of Surgeons.

[22]  K. Menon,et al.  Outcomes after major hepatectomy in elderly patients. , 2006, Journal of the American College of Surgeons.

[23]  S. Brozzetti,et al.  Surgical treatment of pancreatic head carcinoma in elderly patients. , 2006, Archives of surgery.

[24]  P. Royle,et al.  Systematic review of the Sugarbaker procedure for pseudomyxoma peritonei , 2005, The British journal of surgery.

[25]  F. Kwiatkowski,et al.  Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[27]  H. Tinteren,et al.  Toxicity of cytoreductive surgery and hyperthermic intra‐peritoneal chemotherapy , 2004, Journal of surgical oncology.

[28]  E. Cotte,et al.  Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure and Cytoreductive Surgery for the Treatment of Peritoneal Carcinomatosis: Morbidity and Mortality Analysis of 216 Consecutive Procedures , 2003, Annals of Surgical Oncology.

[29]  Takuma Sasaki,et al.  Effective therapy for peritoneal dissemination in gastric cancer. , 2003, Surgical oncology clinics of North America.

[30]  E. Levine,et al.  Long-Term Survivorship and Quality of Life After Cytoreductive Surgery Plus Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis , 2003, Annals of Surgical Oncology.

[31]  K. Jablonski,et al.  Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy , 1995, Annals of surgery.

[32]  D. Elias,et al.  Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  P. Sugarbaker.  New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? , 2006, The Lancet. Oncology.